Search results for: "johnson johnson"

(728 records)
* We recommend refining your query to help us better locate the information you're seeking.

Johnson Matthey acquires Pharmorphix

Cambridge firm provides solid form services that are critical to successful drug discovery and development

UbiVac partners Johnson & Johnson Innovation to develop a vaccine against oral cancer

Will develop new preclinical and clinical versions of its proprietary DRibble immunotherapy
EMD Serono appoints Scott Filosi as Senior Vice President of Managed Markets

EMD Serono appoints Scott Filosi as Senior Vice President of Managed Markets

Filosi brings 20 years of market access experience to the EMD Serono leadership team

2015 Pharma Awards: finalists shortlist

Winners from all seven categories will be unveiled at next month's CPhI Worldwide in Madrid
Ingredients
Johnson Matthey rebrands its Fine Chemicals Division

Johnson Matthey rebrands its Fine Chemicals Division

The rebranding is a key part of a custom-focused initiative to unite Johnson Matthey's diverse fine chemicals capabilities

Michael Meyers joins Syndax Pharmaceuticals as SVP and Chief Development Officer

Brings significant experience in oncology drug development to expanding clinical programme

Ontario Government, University of Toronto and MaRS secure JLABS incubator

JLABS @ Toronto will be a 40,000ft2 facility for up to 50 start-ups focused on biotechnology, pharmaceutical, medical device, consumer and digital health programmes

Alfa Aesar launches exclusive Nanoparticle Design Services

Will allow customers an opportunity to create disruptive technologies through the development of new performance products

Prevalence of diabetes fuels market growth in India

Rising funds for diabetes control is also boosting growth of the diabetes drugs market in India

J&J announces immuno-oncology collaboration with Alligator Bioscience

Alligator will complete the current Phase I study and Janssen will be responsible for all subsequent product development

Mallinckrodt Pharmaceuticals to acquire Therakos for US$1.3bn

Expanding its presence in hospitals

Amneal buys former J&J plant in Tipperary, Ireland

Aims to hire up to 300 people at the facility which will focus on R&D, inhalers and biosimilars

Stem cell therapy will redefine regenerative medicine, says F&S

Globally, this market is expected to be worth US$40bn by 2020 and $180bn by 2030

Catalent and AAPS name competition winners

Four scientists win awards in Global Academic Competition for Life Science Leaders of Tomorrow

Baxalta appoints Jacopo Leonardi as EVP and President Immunology

Biopharmaceutical firm specialises in developing and manufacturing plasma-based therapies for rare diseases
Regulatory
Consistency – the key to quality and compliance

Consistency – the key to quality and compliance

Sharon Johnson, Senior VP, Quality, Product Development & Regulatory Affairs at Catalent, looks at how the newly created US FDA Office of Pharmaceutical Quality aims to...

Trending Articles

  1. Takara Bio extends biomanufacturing capabilities with custom enzyme manufacturing lab Its Gothenburg facility now has a manufacturing lab that can produce customised molecular biology products such as PCR and qPCR enzymes
  2. Axplora earns EcoVadis Platinum, Gold and Silver ratings across four European CDMO manufacturing sites The sustainability ratings recognise Axplora's progress in responsible pharmaceutical manufacturing, with its Leverkusen facility ranking among the top 1% of organisations assessed by EcoVadis
  3. Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    ESG: transforming the pharmaceutical supply chain As pharmaceutical businesses place greater scrutiny on the environmental performance of their supply chains, manufacturers are under growing pressure to show that sustainability is embedded in the way they operate
  5. Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones Piramal Pharma Limited (PPL) (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global platform, investing in differentiated capabilities, advancing sustainability, and delivering quality across operations

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Personal Protection New immersive innovation hub near Coimbra combines safety training, product testing and collaborative R&D to support the future of workplace protection
Ansell opens AXIS Portugal to accelerate PPE innovation in Europe

Ansell opens AXIS Portugal to accelerate PPE innovation in Europe

Read more
Hi Tech Manufacturing Linking the digital twin of the mould with production data. Virtual mould and process optimisation prior to physical construction Mould Lifecycle Management as the foundation...
Gerresheimer significantly accelerates mould development in medical technology with “Digital Mold”

Gerresheimer significantly accelerates mould development in medical technology with “Digital Mold”

Read more
Manufacturing Brings decentralised, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market
DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

Read more
Manufacturing The pharma giant is consolidating parts of its manufacturing network as it advances a $55bn US investment programme aimed at expanding domestic production of advanced medicines
Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

Read more
Manufacturing ten23 health today highlights its research collaboration with dsm-firmenich, focused on expanding excipient options for parenteral biologic drug products
ten23 health expands excipient options for biologic drug development with an external collaboration

ten23 health expands excipient options for biologic drug development with an external collaboration

Read more
Design & Build The clinical-stage biotech has relocated to ARC Oxford, strengthening its R&D capabilities as it progresses clinical trials of its oncolytic immunotherapy candidate THEO-260...
Theolytics expands Oxford biotech operations with new facility to advance THEO-260 cancer immunotherapy

Theolytics expands Oxford biotech operations with new facility to advance THEO-260 cancer immunotherapy

Read more
Research & Development In discussion with Dr Kevin Robinson (KSR), Neurvati’s Dr Bruce Leuchter (BL) explores how biology-led development, better diagnosis and rare disease infrastructure could...
Precision medicine and the fight to revive neuroscience R&D

Precision medicine and the fight to revive neuroscience R&D

Read more
Manufacturing A leading biopharmaceutical manufacturer in England is realising substantial energy savings after upgrading its ageing compressed air system with Atlas Copco’s oil-free VSD+...
Pharmaceutical company cuts energy use and achieves ISO compliance with compressor and dryer upgrade

Pharmaceutical company cuts energy use and achieves ISO compliance with compressor and dryer upgrade

Read more